| 000 | 01445 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250516072446.0 | ||
| 264 | 0 | _c20130708 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1538-7836 | ||
| 024 | 7 |
_a10.1111/j.1538-7836.2011.04602.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCattaneo, M | |
| 245 | 0 | 0 |
_aResponse variability to clopidogrel: is tailored treatment, based on laboratory testing, the right solution? _h[electronic resource] |
| 260 |
_bJournal of thrombosis and haemostasis : JTH _cMar 2012 |
||
| 300 |
_a327-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aPlatelet Function Tests _xstandards |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aPrecision Medicine |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 |
_aPurinergic P2Y Receptor Antagonists _xadverse effects |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2Y12 _xblood |
| 650 | 0 | 4 |
_aTiclopidine _xadverse effects |
| 650 | 0 | 4 | _aTreatment Failure |
| 773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 10 _gno. 3 _gp. 327-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1538-7836.2011.04602.x _zAvailable from publisher's website |
| 999 |
_c21439181 _d21439181 |
||